Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biojuvant is the agriculture business unit and brand of SCD Probiotics, a Kansas City-based company focused on microbial consortia technology. It develops and commercializes microbe-based products for farmers, ranchers, and growers, including inoculants, adjuvants, and biostimulants intended to improve soil, plant, and animal health. The business emphasizes sustainability, yield and quality improvement, feed conversion benefits, and reduced reliance on synthetic chemicals and antibiotics. Based on available sources, Biojuvant appears to be a commercial agricultural-biological brand rather than a drug-development biotech company, and it does not appear to have a human therapeutics pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biojuvant.